UniProt ID | VAPB_HUMAN | |
---|---|---|
UniProt AC | O95292 | |
Protein Name | Vesicle-associated membrane protein-associated protein B/C | |
Gene Name | VAPB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 243 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type IV membrane protein. Present in mitochondria-associated membranes that are endoplasmic reticulum membrane regions closely apposed to the outer mitochondrial membrane. |
|
Protein Description | Participates in the endoplasmic reticulum unfolded protein response (UPR) by inducing ERN1/IRE1 activity. Involved in cellular calcium homeostasis regulation.. | |
Protein Sequence | MAKVEQVLSLEPQHELKFRGPFTDVVTTNLKLGNPTDRNVCFKVKTTAPRRYCVRPNSGIIDAGASINVSVMLQPFDYDPNEKSKHKFMVQSMFAPTDTSDMEAVWKEAKPEDLMDSKLRCVFELPAENDKPHDVEINKIISTTASKTETPIVSKSLSSSLDDTEVKKVMEECKRLQGEVQRLREENKQFKEEDGLRMRKTVQSNSPISALAPTGKEEGLSTRLLALVVLFFIVGVIIGKIAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAKVEQVLS ------CCCCEEHHH | 25.30 | 25944712 | |
3 | Acetylation | -----MAKVEQVLSL -----CCCCEEHHHC | 45.03 | 23954790 | |
3 | Ubiquitination | -----MAKVEQVLSL -----CCCCEEHHHC | 45.03 | 19608861 | |
9 | Phosphorylation | AKVEQVLSLEPQHEL CCCEEHHHCCCCCCC | 31.65 | 23312004 | |
17 | Ubiquitination | LEPQHELKFRGPFTD CCCCCCCEECCCCCC | 29.99 | - | |
17 | Acetylation | LEPQHELKFRGPFTD CCCCCCCEECCCCCC | 29.99 | 26051181 | |
23 | Phosphorylation | LKFRGPFTDVVTTNL CEECCCCCCEEECCE | 30.90 | 27362937 | |
27 | Phosphorylation | GPFTDVVTTNLKLGN CCCCCEEECCEECCC | 15.15 | 27362937 | |
28 | Phosphorylation | PFTDVVTTNLKLGNP CCCCEEECCEECCCC | 27.26 | 27362937 | |
31 | Acetylation | DVVTTNLKLGNPTDR CEEECCEECCCCCCC | 57.32 | 26051181 | |
38 | Methylation | KLGNPTDRNVCFKVK ECCCCCCCCEEEEEE | 39.70 | 115919753 | |
43 | Methylation | TDRNVCFKVKTTAPR CCCCEEEEEECCCCC | 37.38 | - | |
43 | Acetylation | TDRNVCFKVKTTAPR CCCCEEEEEECCCCC | 37.38 | 25953088 | |
99 | Phosphorylation | SMFAPTDTSDMEAVW EEECCCCCHHHHHHH | 29.16 | 28348404 | |
100 | Phosphorylation | MFAPTDTSDMEAVWK EECCCCCHHHHHHHH | 37.46 | 28348404 | |
118 | Ubiquitination | PEDLMDSKLRCVFEL HHHHCCCCCEEEEEE | 35.37 | - | |
118 | Malonylation | PEDLMDSKLRCVFEL HHHHCCCCCEEEEEE | 35.37 | 26320211 | |
118 | Acetylation | PEDLMDSKLRCVFEL HHHHCCCCCEEEEEE | 35.37 | 23749302 | |
131 | Acetylation | ELPAENDKPHDVEIN EECCCCCCCCCEEEC | 56.70 | 26051181 | |
131 | Ubiquitination | ELPAENDKPHDVEIN EECCCCCCCCCEEEC | 56.70 | - | |
139 | Ubiquitination | PHDVEINKIISTTAS CCCEEECEEEEECCC | 47.26 | - | |
142 | Phosphorylation | VEINKIISTTASKTE EEECEEEEECCCCCC | 24.15 | 25867546 | |
143 | Phosphorylation | EINKIISTTASKTET EECEEEEECCCCCCC | 18.90 | 23911959 | |
143 | O-linked_Glycosylation | EINKIISTTASKTET EECEEEEECCCCCCC | 18.90 | 23301498 | |
144 | Phosphorylation | INKIISTTASKTETP ECEEEEECCCCCCCC | 23.34 | 21712546 | |
146 | Phosphorylation | KIISTTASKTETPIV EEEEECCCCCCCCEE | 37.71 | 21712546 | |
147 | Acetylation | IISTTASKTETPIVS EEEECCCCCCCCEEC | 48.17 | 23236377 | |
147 | Ubiquitination | IISTTASKTETPIVS EEEECCCCCCCCEEC | 48.17 | 21906983 | |
147 | Sumoylation | IISTTASKTETPIVS EEEECCCCCCCCEEC | 48.17 | 25114211 | |
147 (in isoform 1) | Ubiquitination | - | 48.17 | 21890473 | |
148 | Phosphorylation | ISTTASKTETPIVSK EEECCCCCCCCEECH | 42.47 | 30266825 | |
150 | Phosphorylation | TTASKTETPIVSKSL ECCCCCCCCEECHHH | 24.44 | 25159151 | |
154 | O-linked_Glycosylation | KTETPIVSKSLSSSL CCCCCEECHHHCCCC | 19.76 | 23301498 | |
154 | Phosphorylation | KTETPIVSKSLSSSL CCCCCEECHHHCCCC | 19.76 | 30266825 | |
155 (in isoform 1) | Ubiquitination | - | 44.51 | 21890473 | |
155 | Acetylation | TETPIVSKSLSSSLD CCCCEECHHHCCCCC | 44.51 | 25953088 | |
155 | Ubiquitination | TETPIVSKSLSSSLD CCCCEECHHHCCCCC | 44.51 | 21890473 | |
156 | Phosphorylation | ETPIVSKSLSSSLDD CCCEECHHHCCCCCH | 26.44 | 29255136 | |
158 | Phosphorylation | PIVSKSLSSSLDDTE CEECHHHCCCCCHHH | 25.60 | 22167270 | |
159 | Phosphorylation | IVSKSLSSSLDDTEV EECHHHCCCCCHHHH | 39.97 | 22167270 | |
160 | Phosphorylation | VSKSLSSSLDDTEVK ECHHHCCCCCHHHHH | 32.23 | 22167270 | |
164 | Phosphorylation | LSSSLDDTEVKKVME HCCCCCHHHHHHHHH | 42.20 | 30266825 | |
167 | Acetylation | SLDDTEVKKVMEECK CCCHHHHHHHHHHHH | 33.16 | 26051181 | |
188 | Acetylation | QRLREENKQFKEEDG HHHHHHHHHHHHHHC | 61.46 | 26051181 | |
188 | Ubiquitination | QRLREENKQFKEEDG HHHHHHHHHHHHHHC | 61.46 | - | |
191 | Acetylation | REENKQFKEEDGLRM HHHHHHHHHHHCCCC | 58.67 | 26051181 | |
201 | Phosphorylation | DGLRMRKTVQSNSPI HCCCCHHHHCCCCCC | 17.26 | 30266825 | |
204 | Phosphorylation | RMRKTVQSNSPISAL CCHHHHCCCCCCCCC | 34.63 | 30266825 | |
206 | Phosphorylation | RKTVQSNSPISALAP HHHHCCCCCCCCCCC | 28.94 | 30266825 | |
209 | Phosphorylation | VQSNSPISALAPTGK HCCCCCCCCCCCCCC | 22.18 | 30266825 | |
214 | Phosphorylation | PISALAPTGKEEGLS CCCCCCCCCCCCCHH | 56.10 | 30266825 | |
216 | Acetylation | SALAPTGKEEGLSTR CCCCCCCCCCCHHHH | 55.88 | 30593321 | |
221 | Phosphorylation | TGKEEGLSTRLLALV CCCCCCHHHHHHHHH | 23.49 | - | |
222 | Phosphorylation | GKEEGLSTRLLALVV CCCCCHHHHHHHHHH | 30.31 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VAPB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VAPB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VAPB_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00058 | Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease | |||||
H00455 | Spinal muscular atrophy (SMA), including: SMA type I (SMA1) / Werdning-Hoffman disease; SMA type II | |||||
OMIM Disease | ||||||
608627 | Amyotrophic lateral sclerosis 8 (ALS8) | |||||
182980 | Spinal muscular atrophy, proximal, adult, autosomal dominant (SMAPAD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-156; SER-160 AND SER-206, AND MASSSPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-156; SER-160 AND SER-206, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-156 ANDSER-160, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-160 ANDSER-206, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-160, ANDMASS SPECTROMETRY. |